A phase II study of the Ras-MAPK signaling pathway...

A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression

Warren P. Mason, Karl Belanger, Garth Nicholas, Isabelle Vallières, David Mathieu, Petr Kavan, Annick Desjardins, Antonio Omuro, Didier Reymond
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
107
Language:
english
Pages:
7
DOI:
10.1007/s11060-011-0747-6
Date:
April, 2012
File:
PDF, 310 KB
english, 2012
Conversion to is in progress
Conversion to is failed